NRx Pharmaceuticals reports progress in clinical trials and partnerships By Investing.com

Published on 1 Apr 2024 on Investing.com

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) has announced significant advancements in its clinical and...

Read the rest of the article

Start tracking your investments with Statfolio

Here are three stocks with buy rank and strong momentum characteristics for investors to consider...

Zacks · via Yahoo Finance 6 Jan 2025

Here are three stocks with buy rank and strong momentum characteristics for investors to consider...

Zacks · via Yahoo Finance 30 Dec 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: CoreCard Corporation CCR...

Zacks · via Yahoo Finance 29 Dec 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: eGain Corporation EGAN: ...

Zacks · via Yahoo Finance 26 Dec 2024

NRx Pharmaceuticals, Inc. (NRXP) closed the latest trading day at $3.04, indicating a +0.66% chan...

Zacks via Yahoo Finance 19 Apr 2024

U.S. stocks traded mostly lower toward the end of trading, with the NASDAQ Composite falling arou...

Benzinga 18 Apr 2024

Shares of Las Vegas Sands Corp. LVS fell sharply during Thursday's session despite better-than-ex...

Benzinga 18 Apr 2024

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Investing.com 18 Apr 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)("NRx Pharmaceuticals" or the "Company"), a clinical-stag...

Rome Sentinel 17 Apr 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Dell Technologies Inc. D...

Zacks via Yahoo Finance 4 Apr 2024